|
|
Prostate Cancer 2003: New Perspectives
October 10-11, 2003
Harbor Court Hotel
Baltimore, Maryland
|
| |
| Acknowledgment |
“Prostate Cancer 2003: New Perspectives” is supported in part by unrestricted educational grants from Abbott Laboratories, Amgen, Inc., AstraZeneca Pharmaceuticals, Aventis Oncology, Cytogen Corporation, Diagnostic Ultrasound, and Novartis Phamaceuticals.
|
| |
|
Agenda
|
|
Download the brochure in PDF format
|
| Friday, October 10, 2003 |
| Session I | Prostate Cancer and the Primary Care Physician |
| 7:00 am–8:00 am | Registration and Continental Breakfast |
| 8:00 am–8:05 am | Welcome Remarks |
| 8:05 am–8:30 am | Prostate Cancer Prevention/Risk Factor Reduction |
| William Nelson, MD, PhD |
| 8:30 am–8:55 am | Epidemiology of Prostate Cancer |
| Elizabeth A. Platz, ScD, MPH |
| 8:55 am–9:20 am | Prostate Cancer Screening |
| Peter Albertsen, MD |
| 9:20 am–9:45 am | Proliferative Atrophy-Precancer Molecular Markers |
| Angelo DeMarzo, MD, PhD |
| 9:45 am–10:15 am | Panel Discussion |
| 10:15 am–10:45 am | Break and Visit Exhibits |
| |
| |
| Session II | Approaches to the Patient with Rising PSA |
| 10:45 am–11:10 am | Salvage Conformal Radiation and Predictors of Outcome |
| Michael J. Zelefsky, MD |
| 11:10 am–11:35 am | Salvage Prostatectomy Gary D. Steinberg, MD |
| 11:35 am–12:00 noon | PSA Targeted/Delivered Therapy |
| Samuel Denmeade, MD |
| 12:00 noon–1:00 pm | Lunch and Visit Exhibits |
| 1:00 pm–1:30 pm | Chemotherapy vs Biologics Debate |
| Nancy A. Dawson, MD and Michael A. Carducci, MD |
| 1:30 pm–1:55 pm | Trial Design |
| Howard Scher, MD |
| 1:55 pm–2:20 pm | Diet and Lifestyle Recommendations for the Prostate Cancer Patient: Novel Approach to PSA Reduction |
| Mark A. Moyad, MPH |
| 2:20 pm–2:50 pm | Panel Discussion |
| 2:50 pm–3:20 pm | Break and Visit Exhibits |
| |
| |
| Session III | Localized Prostate Cancer |
| 3:20 pm–3:45 pm | Imaging Modalities |
| Roberto Pili, MD |
| 3:45 pm–4:10 pm | Multimodality Management of High-Risk Localized Disease |
| Maha Hussain, MD |
| 4:10 pm–4:35 pm | Nerve-Sparing Cryosurgery—“Male Lumpectomy” |
| Gary Onik, MD |
| 4:35 pm–5:00 pm | Robotic Surgery |
| James Peabody, MD |
| 5:00 pm–5:30 pm | Panel Discussion |
| 6:30 pm | Reception |
| |
| |
| Visionary Art Museum |
| Saturday, October 11, 2003 |
| Session IV Advanced Prostate Cancer, Part 1 |
| 8:00 am–8:25 am | The Biology of Prostate Cancer Progression |
| David Nanus, MD |
| 8:25 am–8:50 am | New Hormonal Therapy Approaches |
| Judd W. Moul, MD |
| 8:50 am–9:15 am | Protease Activity and Bone Metastases |
| Michael L. Cher, MD |
| 9:15 am–9:40 am | Treatment of Prostate Cancer with Humanized Monoclonal |
| |
| |
| Antibody to PSMA |
| Neil Bander, MD |
| 9:40 am–10:10 am | Panel Discussion |
| 10:10 am–10:40 am | Break and Visit Exhibits |
| |
| |
| Saturday, October 11, 2003 (cont’d) |
| Session V Advanced Prostate Cancer, Part 2 |
| 10:40 am–11:05 am | Health-Related QOL in Metastatic Prostate Cancer |
| David F. Penson, MD, MPH |
| 11:05 am–11:30 am | QOL Tools |
| David Osoba, MD |
| 11:30 am–11:55 am | Update on Chemotherapy |
| William Dahut, MD |
| 11:55 am–12:20 pm | Growth Factors as a Target for Prostate |
| |
| |
| Cancer Treatment |
| Daniel George, MD |
| 12:20 pm–12:45 pm | Update on Bisphosphonates |
| Nancy A. Dawson, MD |
| 12:45 pm | Adjourn |
| 12:45 pm–1:30 pm | Lunch and Visit Exhibits |
|
|
|
